Burns Ricky, Lynch Sean T, Staudenmaier Paige, Becker Timothy D, Shanker Parul, Martin Dalton, Leong Alicia, Rice Timothy
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Psychiatry, Mount Sinai Behavioral Health Center, 45 Rivington Street, New York, NY, 10002, USA.
Child Psychiatry Hum Dev. 2025 May 16. doi: 10.1007/s10578-025-01852-0.
This study examined biopsychosocial factors associated with the use of intramuscular (IM) agitation emergency medication in child and adolescent psychiatric inpatients. A retrospective review of 1,101 patients hospitalized between June 2018-November 2021 at an urban teaching hospital identified predictors of IM medication use through linear regression analysis. Among these patients, 196 received IM medication during their stay. Female sex was associated with a lower likelihood of receiving IM treatment, while factors such as prior involvement with child protective services, a history of violence, previous psychiatric hospitalizations, and use of multiple home psychiatric medications increased the likelihood. Agitation episodes pose risks to both patients and staff, underscoring the importance of early identification and intervention. Understanding these risk factors may guide proactive strategies to reduce the frequency and severity of agitation and limit reliance on emergency pharmacological interventions. Further research is needed to refine predictive models and explore non-pharmacological management approaches.
本研究调查了与儿童和青少年精神科住院患者使用肌内注射（IM）抗躁狂应急药物相关的生物心理社会因素。通过对一家城市教学医院在2018年6月至2021年11月期间住院的1101名患者进行回顾性研究，采用线性回归分析确定了使用IM药物的预测因素。在这些患者中，196人在住院期间接受了IM药物治疗。女性接受IM治疗的可能性较低，而诸如之前与儿童保护服务机构有过接触、暴力史、既往精神科住院史以及使用多种家庭精神科药物等因素会增加接受IM治疗的可能性。躁狂发作对患者和工作人员都构成风险，这凸显了早期识别和干预的重要性。了解这些风险因素可能会指导采取积极策略，以减少躁狂发作的频率和严重程度，并限制对应急药物干预的依赖。需要进一步研究以完善预测模型并探索非药物管理方法。
